Cite
Tsuruta M, Ueda S, Yew PY, et al. Bladder cancer-associated cancer-testis antigen-derived long peptides encompassing both CTL and promiscuous HLA class II-restricted Th cell epitopes induced CD4. Oncoimmunology. 2018;7(4):e1415687doi: 10.1080/2162402X.2017.1415687.
Tsuruta, M., Ueda, S., Yew, P. Y., Fukuda, I., Yoshimura, S., Kishi, H., Hamana, H., Hirayama, M., Yatsuda, J., Irie, A., Senju, S., Yuba, E., Kamba, T., Eto, M., Nakayama, H., & Nishimura, Y. (2018). Bladder cancer-associated cancer-testis antigen-derived long peptides encompassing both CTL and promiscuous HLA class II-restricted Th cell epitopes induced CD4. Oncoimmunology, 7(4), e1415687. https://doi.org/10.1080/2162402X.2017.1415687
Tsuruta, Miki, et al. "Bladder cancer-associated cancer-testis antigen-derived long peptides encompassing both CTL and promiscuous HLA class II-restricted Th cell epitopes induced CD4." Oncoimmunology vol. 7,4 (2018): e1415687. doi: https://doi.org/10.1080/2162402X.2017.1415687
Tsuruta M, Ueda S, Yew PY, Fukuda I, Yoshimura S, Kishi H, Hamana H, Hirayama M, Yatsuda J, Irie A, Senju S, Yuba E, Kamba T, Eto M, Nakayama H, Nishimura Y. Bladder cancer-associated cancer-testis antigen-derived long peptides encompassing both CTL and promiscuous HLA class II-restricted Th cell epitopes induced CD4. Oncoimmunology. 2018 Jan 05;7(4):e1415687. doi: 10.1080/2162402X.2017.1415687. eCollection 2018. PMID: 29632734; PMCID: PMC5889196.
Copy
Download .nbib